Regina M. Benjamin sold $3.0M of DOCS
director at Doximity, Inc.. 40,000 shares at an average of $76.15, traded Feb 11, 2025, filed Feb 13, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.0M at market
- +20Share of holdings soldSold 71% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001516513-25-000025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 11, 2025 | CConversion Class A Common Stock | +40,000 | - | - | 56,618 | Feb 13, 2025 |
| Feb 11, 2025 | SOpen-market sale Class A Common Stock | -6,956 | $75.00 | $522k | 49,662 | Feb 13, 2025 |
| Feb 11, 2025 | SOpen-market sale Class A Common Stock | -22,835 | $75.93 | $1.7M | 26,827 | Feb 13, 2025 |
| Feb 11, 2025 | SOpen-market sale Class A Common Stock | -6,623 | $76.83 | $509k | 20,204 | Feb 13, 2025 |
| Feb 11, 2025 | SOpen-market sale Class A Common Stock | -2,886 | $78.18 | $226k | 17,318 | Feb 13, 2025 |
| Feb 11, 2025 | SOpen-market sale Class A Common Stock | -700 | $79.67 | $56k | 16,618 | Feb 13, 2025 |
| Feb 11, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -40,000 | $0.00 | $0 | 381,138 | Feb 13, 2025 |
| Feb 11, 2025 | MOption exercise Class B Common Stockderivative | +40,000 | $0.00 | $0 | 40,000 | Feb 13, 2025 |
| Feb 11, 2025 | CConversion Class B Common Stockderivative | -40,000 | $0.00 | $0 | 0 | Feb 13, 2025 |
Related signals
Other insiders at Doximity, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Doximity, Inc. | Kira Scherer Wampler director | $58k 2,000 shares | -7% | |
| 9Weak | Doximity, Inc. | Watkin Phoebe L. Yang director | $34k 1,290 shares | -5% | |
| 0Weak | Doximity, Inc. | Siddharth Sitaram Chief Accounting Officer | $54k 2,077 shares | -2% | |
| 0Weak | Doximity, Inc. | Kira Scherer Wampler director | $53k 2,000 shares | -7% | |
| 17Weak | Doximity, Inc. | Regina M. Benjamin director | $600k 10,000 shares | -38% | |
| 27Weak | Doximity, Inc. | Timothy S Cabral director | $600k 10,000 shares | -61% | |
| 3Weak | Doximity, Inc. | Kira Scherer Wampler director | $106k 2,000 shares | -11% | |
| 26Weak | Doximity, Inc. | Timothy S Cabral director | $506k 10,000 shares | -61% | |
| 25Weak | Doximity, Inc. | Anna Bryson Chief Financial Officer | $5.6M 95,000 shares | -24% | |
| 3Weak | Doximity, Inc. | Kira Scherer Wampler director | $114k 2,000 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.